Global Glance: Pfizer buys Anacor Pharmaceuticals, Oklahoma eyes Medicaid expansion

Powered by The Associated Press

Here are today’s top business headlines from across the nation and world:

Pfizer buying Anacor Pharmaceuticals in $5.2 billion deal

NEW YORK (AP) — Pfizer will acquire Anacor Pharmaceuticals Inc. in a deal valued at about $5.2 billion. Anacor’s topical treatment for eczema, called crisaborole, is currently under review by the Food and Drug Administration. If approved, Pfizer said it believes peak year sales could reach or exceed $2 billion. Anacor, based in Palo Alto, California, also holds the rights to a topical treatment for toenail fungus called Kerydin. Read more


Global stocks mixed after disappointing China factory data

BEIJING (AP) — Global stocks were mixed early Monday after disappointing Chinese factory data and last week’s Wall Street decline, as European shares fell while Asia was mostly higher. Read more


In surprising turnabout, Oklahoma eyes Medicaid expansion

OKLAHOMA CITY (AP) — Despite bitter resistance in Oklahoma for years to President Barack Obama’s health care overhaul, Republican leaders in this conservative state are now confronting something that alarms them even more: a huge $1.3 billion hole in the budget that threatens to do widespread damage to the state’s health care system. So, in what would be the grandest about-face among rightward leaning states, Oklahoma is now moving toward a plan to expand its Medicaid program. Read more


Verizon, unions set to return to bargaining table

NEW YORK (AP) — USA Today owner Gannett has boosted its takeover bid for Tribune Publishing Co. by about 22 percent one week after the owner of the Los Angeles Times, Chicago Tribune and other newspapers adopted a “poison pill” plan to thwart the unsolicited offer. Read more


Gannett raises offer for Tribune Publishing by 22 percent

NEW YORK (AP) — USA Today owner Gannett has boosted its takeover bid for Tribune Publishing Co. by about 22 percent one week after the owner of the Los Angeles Times, Chicago Tribune and other newspapers adopted a “poison pill” plan to thwart the unsolicited offer. Read more

Leave a Reply

Have you heard?

Missouri Business Alert is participating in CoMoGives2019!

Find out how we plan to use your gift to enhance training and programming for our students